IBDEI2KU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41128,2)
 ;;=^5008233
 ;;^UTILITY(U,$J,358.3,41129,0)
 ;;=J42.^^152^2026^21
 ;;^UTILITY(U,$J,358.3,41129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41129,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,41129,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,41129,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,41130,0)
 ;;=J43.0^^152^2026^29
 ;;^UTILITY(U,$J,358.3,41130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41130,1,3,0)
 ;;=3^Emphysema,Pulmonary,Unilateral
 ;;^UTILITY(U,$J,358.3,41130,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,41130,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,41131,0)
 ;;=J43.1^^152^2026^28
 ;;^UTILITY(U,$J,358.3,41131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41131,1,3,0)
 ;;=3^Emphysema,Panlobular
 ;;^UTILITY(U,$J,358.3,41131,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,41131,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,41132,0)
 ;;=J43.2^^152^2026^26
 ;;^UTILITY(U,$J,358.3,41132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41132,1,3,0)
 ;;=3^Emphysema,Centrilobular
 ;;^UTILITY(U,$J,358.3,41132,1,4,0)
 ;;=4^J43.2
 ;;^UTILITY(U,$J,358.3,41132,2)
 ;;=^5008237
 ;;^UTILITY(U,$J,358.3,41133,0)
 ;;=J43.8^^152^2026^27
 ;;^UTILITY(U,$J,358.3,41133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41133,1,3,0)
 ;;=3^Emphysema,Other
 ;;^UTILITY(U,$J,358.3,41133,1,4,0)
 ;;=4^J43.8
 ;;^UTILITY(U,$J,358.3,41133,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,41134,0)
 ;;=J43.9^^152^2026^30
 ;;^UTILITY(U,$J,358.3,41134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41134,1,3,0)
 ;;=3^Emphysema,Unspec
 ;;^UTILITY(U,$J,358.3,41134,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,41134,2)
 ;;=^5008238
 ;;^UTILITY(U,$J,358.3,41135,0)
 ;;=J44.0^^152^2026^23
 ;;^UTILITY(U,$J,358.3,41135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41135,1,3,0)
 ;;=3^COPD w/ (Acute) Lower Resp Infection
 ;;^UTILITY(U,$J,358.3,41135,1,4,0)
 ;;=4^J44.0
 ;;^UTILITY(U,$J,358.3,41135,2)
 ;;=^5008239
 ;;^UTILITY(U,$J,358.3,41136,0)
 ;;=J45.20^^152^2026^5
 ;;^UTILITY(U,$J,358.3,41136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41136,1,3,0)
 ;;=3^Asthma,Mild Intermittent,Uncompl
 ;;^UTILITY(U,$J,358.3,41136,1,4,0)
 ;;=4^J45.20
 ;;^UTILITY(U,$J,358.3,41136,2)
 ;;=^5008242
 ;;^UTILITY(U,$J,358.3,41137,0)
 ;;=J45.21^^152^2026^3
 ;;^UTILITY(U,$J,358.3,41137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41137,1,3,0)
 ;;=3^Asthma,Mild Intermittent w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,41137,1,4,0)
 ;;=4^J45.21
 ;;^UTILITY(U,$J,358.3,41137,2)
 ;;=^5008243
 ;;^UTILITY(U,$J,358.3,41138,0)
 ;;=J45.22^^152^2026^4
 ;;^UTILITY(U,$J,358.3,41138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41138,1,3,0)
 ;;=3^Asthma,Mild Intermittent w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,41138,1,4,0)
 ;;=4^J45.22
 ;;^UTILITY(U,$J,358.3,41138,2)
 ;;=^5008244
 ;;^UTILITY(U,$J,358.3,41139,0)
 ;;=J45.31^^152^2026^6
 ;;^UTILITY(U,$J,358.3,41139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41139,1,3,0)
 ;;=3^Asthma,Mild Persistent w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,41139,1,4,0)
 ;;=4^J45.31
 ;;^UTILITY(U,$J,358.3,41139,2)
 ;;=^5008246
 ;;^UTILITY(U,$J,358.3,41140,0)
 ;;=J45.32^^152^2026^7
 ;;^UTILITY(U,$J,358.3,41140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41140,1,3,0)
 ;;=3^Asthma,Mild Persistent w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,41140,1,4,0)
 ;;=4^J45.32
 ;;^UTILITY(U,$J,358.3,41140,2)
 ;;=^5008247
 ;;^UTILITY(U,$J,358.3,41141,0)
 ;;=J45.40^^152^2026^10
